Get Our FREE Newsletter

Sign Up

Life science-focused SPAC BioPlus Acquisition files for a $220 million IPO

Spread the love

BioPlus Acquisition, a blank check company targeting life sciences, filed on Tuesday with the SEC to raise up to $220 million in an initial public offering.

The New York, NY-based company plans to raise $220 million by offering 22 million units at $10 per unit. Each unit contain

This post was originally published on this site